FASTINOV and Quilaban presented ultra-rapid antimicrobial susceptibility testing at the XIII Portuguese National Clinical Pathology Congress in the Algarve. The participation brought the technology into a national forum focused on practical challenges in clinical pathology.
Connecting rapid AST with clinical practice
The congress provided an opportunity to discuss how faster susceptibility information can support the management of serious infections. The presentation focused on the time between a positive blood culture and the availability of actionable AST information.
A partnership focused on implementation
FASTINOV contributed the technology and scientific perspective, while Quilaban brought local distribution and laboratory-market experience. Together, the companies presented a pathway for introducing ultra-rapid testing into existing clinical microbiology workflows.
The congress participation showed how technology and local implementation support can work together to bring faster AST workflows closer to Portuguese laboratories.